Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lab Industry Says PAMA Reimbursement Rates Not Really Market-Based

Executive Summary

The US Medicare agency was supposed to peg its Clinical Lab Fee Schedule reimbursement rates for 2018 to market-based prices supplied by labs under the 2014 Protecting Access to Medicare Act. The exercise might have increased payment rates for lab tests, but clinical labs say that the new Medicare rates actually make deep cuts that could disrupt access to laboratory services.

Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

MT121554

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel